First Turn Management »

Disc Medicine shares owned by First Turn Management

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by First Turn Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.1M 157k 57.76

More positions owned by First Turn Management

Cytokinetics Com New (CYTK)
Cymabay Therapeutics
Vertex Pharmaceuticals Incorporated (VRTX)
Argenx Se Sponsored Adr (ARGX)
Xenon Pharmaceuticals (XENE)
Krystal Biotech (KRYS)
Legend Biotech Corp Sponsored Ads (LEGN)
Karuna Therapeutics Ord
Transmedics Group (TMDX)
Insulet Corporation (PODD)
Day One Biopharmaceuticals I (DAWN)
Mirum Pharmaceuticals (MIRM)
Verona Pharma Sponsored Ads (VRNA)
Dex (DXCM)
Axsome Therapeutics (AXSM)

View all positions for First Turn Management

Top funds holding Disc Medicine

Atlas Venture Life Science Advisors
Paradigm Biocapital Advisors
OrbiMed Advisors
Perceptive Advisors
Frazier Life Sciences Management
Vanguard Group
T. Rowe Price Associates
Deerfield Management Company
Henderson Group
Alliancebernstein
Caption Management
5AM Venture Management
Franklin Resources
Citadel Advisors
Ikarian Capital

View all funds holding Disc Medicine